Perspective Therapeutics
(AMEX:CATX)
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Perspective Therapeutics Stock (AMEX:CATX), Quotes and News Summary

Perspective Therapeutics Stock (AMEX: CATX) stock price, news, charts, stock research, profile.

Open$1.670
Close$1.690
Volume / Avg.6.370M / 4.059M
Day Range1.650 - 1.770
52 Wk Range0.205 - 1.700
Market Cap$997.757M
P/E Ratio-
Dividend Yield-
ExchangeAMEX
RSI
68
Short Interest
1.74%
Days to Cover2.18

Recent News

Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions.
Piero Cingari
Expensify And 3 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Avi Kapoor
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by more than 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Jan
1
Mar
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Perspective Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneer...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CATX
MGNX

FAQ

Q

How do I buy Perspective Therapeutics (CATX) stock?

A

You can purchase shares of Perspective Therapeutics (AMEX: CATX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Perspective Therapeutics's (CATX) competitors?

A

Other companies in Perspective Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).

Q

What is the target price for Perspective Therapeutics (CATX) stock?

A

The latest price target for Perspective Therapeutics (AMEX: CATX) was reported by B. Riley Securities on Tuesday, April 9, 2024. The analyst firm set a price target for 1.70 expecting CATX to fall to within 12 months (a possible NaN% downside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Perspective Therapeutics (CATX)?

A

The stock price for Perspective Therapeutics (AMEX: CATX) is $ last updated .

Q

Does Perspective Therapeutics (CATX) pay a dividend?

A

There are no upcoming dividends for Perspective Therapeutics.

Q

When is Perspective Therapeutics (AMEX:CATX) reporting earnings?

A

Perspective Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Perspective Therapeutics (CATX) going to split?

A

There is no upcoming split for Perspective Therapeutics.

Q

What sector and industry does Perspective Therapeutics (CATX) operate in?

A

Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

People Also Watch